Fixed-dose combinations improve medication compliance: a meta-analysis.
about
ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD - SummaryOne Pill, Four Questions: What we Still need to Know about Reducing Cardiovascular Risk with Combination TherapyFixed-dose combination therapy for the prevention of cardiovascular diseaseInterventions for improving adherence to ocular hypotensive therapyOveractive bladder: strategies to ensure treatment compliance and adherencePatient considerations in type 2 diabetes - role of combination dapagliflozin-metformin XRClinical use of cobicistat as a pharmacoenhancer of human immunodeficiency virus therapyLong-term safety and efficacy of telmisartan/amlodipine single pill combination in the treatment of hypertensionThe Effect on Treatment Adherence of Administering Drugs as Fixed-Dose Combinations versus as Separate Pills: Systematic Review and Meta-AnalysisSpotlight on empagliflozin/metformin fixed-dose combination for the treatment of type 2 diabetes: a systematic reviewA fixed-dose combination of memantine extended-release and donepezil in the treatment of moderate-to-severe Alzheimer's diseaseAlogliptin benzoate for management of type 2 diabetesSecular Trends in Prescription Patterns of Single-Pill Combinations of an Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Plus a Thiazide Diuretic for Hypertensive Patients in TaiwanFixed-Dose Combination Drug Approvals, Patents and Market Exclusivities Compared to Single Active Ingredient PharmaceuticalsEfficacy and Safety of 'Fixed Dose' versus 'Loose' Drug Regimens for Treatment of Pulmonary Tuberculosis in Two High TB-Burden African Countries: A Randomized Controlled TrialFixed-dose combination therapy for the prevention of atherosclerotic cardiovascular diseases.The use of H2 antagonists in treating and preventing NSAID-induced mucosal damage.Evaluation of the performance characteristics of bilayer tablets: Part I. Impact of material properties and process parameters on the strength of bilayer tablets.Aspirin and proton pump inhibitor combination therapy for prevention of cardiovascular disease and Barrett's esophagus.Would primary healthcare professionals prescribe a polypill to manage cardiovascular risk? A qualitative interview study.Use of Pharmacy Sales Data to Assess Changes in Prescription- and Payment-Related Factors that Promote Adherence to Medications Commonly Used to Treat Hypertension, 2009 and 2014.Safety of Fixed Dose of Antihypertensive Drug Combinations Compared to (Single Pill) Free-Combinations: A Nested Matched Case-Control Analysis.Effect of single tablet of fixed-dose amlodipine and atorvastatin on blood pressure/lipid control, oxidative stress, and medication adherence in type 2 diabetic patients.Single-Pill Combination of Perindopril/Indapamide/Amlodipine in Patients with Uncontrolled Hypertension: A Randomized Controlled Trial.Anti-hypertensive drugs in children and adolescentsEfficacy and safety of a lercanidipine/enalapril fixed-dose combination in hypertensive patients in PortugalEfficacy and safety of benzalkonium chloride-free fixed-dose combination of latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension.Effect of Switching From an Anti-Diabetic Loose Dose Combination to a Fixed Dose Combination Regimen at Equivalent Dosage for 6 Months on Glycemic Control in Japanese Patients With Type 2 Diabetes: A Pilot Study.Efficacy of aliskiren/hydrochlorothiazide combination for the treatment of hypertension: a meta-analytical approach.Efficacy and safety of valsartan/amlodipine single-pill combination in 11,422 Chinese patients with hypertension: an observational study.Management of hypertension with the fixed combination of perindopril and amlodipine in daily clinical practice: results from the STRONG prospective, observational, multicenter study.Do we need more than just powerful blood pressure reductions? New paradigms in end-organ protectionSimulating the impact of improved cardiovascular risk interventions on clinical and economic outcomes in Russia.The economics of medicines optimization: policy developments, remaining challenges and research priorities.Aliskiren and valsartan combination therapy for the management of hypertension.Triple combination therapy with amlodipine, valsartan, and hydrochlorothiazide vs dual combination therapy with amlodipine and hydrochlorothiazide for stage 2 hypertensive patientsBioequivalence Comparison of Two Formulations of Fixed-Dose Combination Glimepiride/Metformin (2/500 mg)Tablets in Healthy VolunteersHypertension management 2011: optimal combination therapy.Effects on office and home blood pressure of the lercanidipine-enalapril combination in patients with Stage 2 hypertension: a European randomized, controlled clinical trial.Adherence to self-administered tuberculosis treatment in a high HIV-prevalence setting: a cross-sectional survey in Homa Bay, Kenya.
P2860
Q22241786-C3EC5DA7-E220-4DFE-9B0A-B829E2480B7FQ24194960-17D0AE81-BB16-4B0D-A8F3-1A0DE4F210AAQ24195065-8C689557-D210-4219-8990-D773DCD4D7D4Q24241641-0A6CFF90-A99E-4D6B-8D9F-6F309CE70406Q26746914-5523A7C8-5F2C-4CFB-AFD7-23802561074AQ26766404-4CE1843B-1958-4F27-989F-F72A8F3309EBQ26771182-95460E16-9146-4E68-8039-8B239A053BD4Q26824261-5E4BB9FB-4DFA-4772-80EC-681929CBA87EQ26865049-FCF2565C-4506-4E3D-A9EE-391DDD58C8B9Q28071386-F69BE0B7-8830-4243-A2D1-320643B0459EQ28076715-79A87DEC-8C86-4ED9-96ED-2EC3E3026401Q28083933-A2B947F5-23B5-4795-A029-1142A5EBCF04Q28468718-035F3E1F-8B44-4189-8778-FEEC6E8E794CQ28550319-909CF3C7-27A6-44D5-A233-89B554FCC4FAQ28551970-86835549-6517-4C6A-B60F-3185EB513590Q30235416-9BEF842C-D6B8-4F6C-9026-8B97064778FAQ30415171-2E06E9FB-AEF2-488D-96E6-2CB7820910B3Q30449327-934EECDF-6FCA-450C-8849-165DC6FC22C2Q30457290-3A439E69-1C2B-4A17-BAA2-DEC8537DF6FBQ30538222-D1D2241D-F20A-48CC-883B-153FCD524B02Q31115388-858E91BA-A0C9-402E-B0CB-3CCFE9DAE54BQ33166549-5110F8B0-F3F3-4821-82DD-ECBB7CB1AAE2Q33655267-4E78A199-8E61-49BC-B792-88A1F9DA89D0Q33734032-536A5632-47BB-4AA7-8FB5-91CBA5EF56BBQ33772773-9163EF6B-1621-4CB7-925A-52465E65C5E8Q33804767-F5908218-44AF-4483-8833-9A3E02E20A6BQ33857744-87250CC6-FA2C-4644-A8D1-20DCFE388F4FQ33893969-19A90ADF-464C-4D4D-B4D9-EEE69DF0F001Q33928738-4EAF561D-6E6C-4EBB-9A31-0BFF6A4580D6Q33970085-23334B90-1605-4F80-AC12-55229ECB403DQ34017649-B0641BA9-7015-4716-A3A1-49FCB49866A4Q34068728-1D5147E8-9E11-4F9D-A916-AE8631AFB8AFQ34070294-1CF7AEC7-4E15-4EB0-A3B5-622BDCBF3AAAQ34132415-1D0AFB2D-D5E4-44FE-8710-65C0D433EF12Q34139070-243FE8E1-8CC3-45AC-BC35-CE6858E4E0AEQ34139120-08093601-517B-4FEF-9982-A73576905E1AQ34146068-D4D19122-1031-44E9-81F6-BEC63C9630BEQ34194758-DD90AAC6-2E12-4724-8EA8-B608952A6AF0Q34197044-8DD01485-076F-4534-B6B0-49C7CC02296FQ34199723-5B76628B-8177-40F4-8A39-E5BC18178C97
P2860
Fixed-dose combinations improve medication compliance: a meta-analysis.
description
2007 nî lūn-bûn
@nan
2007 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Fixed-dose combinations improve medication compliance: a meta-analysis.
@ast
Fixed-dose combinations improve medication compliance: a meta-analysis.
@en
Fixed-dose combinations improve medication compliance: a meta-analysis.
@nl
type
label
Fixed-dose combinations improve medication compliance: a meta-analysis.
@ast
Fixed-dose combinations improve medication compliance: a meta-analysis.
@en
Fixed-dose combinations improve medication compliance: a meta-analysis.
@nl
prefLabel
Fixed-dose combinations improve medication compliance: a meta-analysis.
@ast
Fixed-dose combinations improve medication compliance: a meta-analysis.
@en
Fixed-dose combinations improve medication compliance: a meta-analysis.
@nl
P2093
P1476
Fixed-dose combinations improve medication compliance: a meta-analysis
@en
P2093
Franz H Messerli
Gayathri Kamalakkannan
Sanobar Parkar
P304
P356
10.1016/J.AMJMED.2006.08.033
P407
P577
2007-08-01T00:00:00Z